Mutational Analysis in Non-Small Cell Lung Cancer


Related Videos (117)

Director of the Thoracic Oncology Program at the Abramson Cancer Center, Corey Langer, MD, discusses recent interpretations of the mutational profile for non-small cell lung cancer (NSCLC), what this knowledge reveals about the patient population, and how it is being translated into clinical trials for new therapies targeting specific mutations in NSCLC.


Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®